首页 > 最新文献

中华内科杂志最新文献

英文 中文
[A trend to screen primary aldosteronism not interfering the administration of common antihypertensive drugs]. [筛查原发性醛固酮增多症的趋势不会干扰常用降压药的使用]。
Pub Date : 2024-09-01 DOI: 10.3760/cma.j.cn112138-20240110-00024
Y Jing, J B Hu, S M Yang, Y Song, Q F Li
{"title":"[A trend to screen primary aldosteronism not interfering the administration of common antihypertensive drugs].","authors":"Y Jing, J B Hu, S M Yang, Y Song, Q F Li","doi":"10.3760/cma.j.cn112138-20240110-00024","DOIUrl":"10.3760/cma.j.cn112138-20240110-00024","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress on clinical features and pathogenesis of anti-gp210-positive primary biliary cholangitis]. [抗gp210阳性原发性胆汁性胆管炎的临床特征和发病机制研究进展]。
Pub Date : 2024-09-01 DOI: 10.3760/cma.j.cn112138-20230901-00104
Z Yang, X Y Wang, Y Ran, L Li, B M Wang, L Zhou
{"title":"[Research progress on clinical features and pathogenesis of anti-gp210-positive primary biliary cholangitis].","authors":"Z Yang, X Y Wang, Y Ran, L Li, B M Wang, L Zhou","doi":"10.3760/cma.j.cn112138-20230901-00104","DOIUrl":"10.3760/cma.j.cn112138-20230901-00104","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Homozygous ABCA1 gene mutated Tangier disease complicated with diabetes mellitus: a case report]. [同型 ABCA1 基因突变的丹吉尔病并发糖尿病:一份病例报告]。
Pub Date : 2024-09-01 DOI: 10.3760/cma.j.cn112138-20240129-00084
C W Liu, J L Yang, X F Fan
{"title":"[Homozygous ABCA1 gene mutated Tangier disease complicated with diabetes mellitus: a case report].","authors":"C W Liu, J L Yang, X F Fan","doi":"10.3760/cma.j.cn112138-20240129-00084","DOIUrl":"10.3760/cma.j.cn112138-20240129-00084","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[IgA nephropathy: current treatment status, prospects, opportunities, and challenges]. [IgA 肾病:治疗现状、前景、机遇和挑战]。
Pub Date : 2024-08-01 DOI: 10.3760/cma.j.cn112138-20240701-00414
H Y Yang, J C Lyu, H Zhang
{"title":"[IgA nephropathy: current treatment status, prospects, opportunities, and challenges].","authors":"H Y Yang, J C Lyu, H Zhang","doi":"10.3760/cma.j.cn112138-20240701-00414","DOIUrl":"10.3760/cma.j.cn112138-20240701-00414","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141790149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Adult-onset immunodeficiency mediated by anti-IFN-γ autoantibody combined with disseminated mycobacterium marseillense infection: a case report]. [抗-IFN-γ自身抗体介导的成人免疫缺陷症合并播散性马氏分枝杆菌感染:一份病例报告]。
Pub Date : 2024-08-01 DOI: 10.3760/cma.j.cn112138-20230816-00061
J J Liu, L Qin, Y Cong, H T Liu, J P Fan, H W Fan, B T Zhou, W Cao
{"title":"[Adult-onset immunodeficiency mediated by anti-IFN-γ autoantibody combined with disseminated mycobacterium marseillense infection: a case report].","authors":"J J Liu, L Qin, Y Cong, H T Liu, J P Fan, H W Fan, B T Zhou, W Cao","doi":"10.3760/cma.j.cn112138-20230816-00061","DOIUrl":"10.3760/cma.j.cn112138-20230816-00061","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141790145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Standardized diagnosis and follow-up of thyroid nodules]. [甲状腺结节的标准化诊断和随访]。
Pub Date : 2024-08-01 DOI: 10.3760/cma.j.cn112138-20240326-00194
X H Yu, K X Wang
{"title":"[Standardized diagnosis and follow-up of thyroid nodules].","authors":"X H Yu, K X Wang","doi":"10.3760/cma.j.cn112138-20240326-00194","DOIUrl":"10.3760/cma.j.cn112138-20240326-00194","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141790153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[X-linked adrenal hypoplasia congenita caused by a novel mutation in NR0B1 (DAX1): a case report]. [由 NR0B1 (DAX1) 基因新型突变引起的 X 连锁先天性肾上腺发育不全:病例报告]。
Pub Date : 2024-08-01 DOI: 10.3760/cma.j.cn112138-20240207-00102
J Du, Y Long, X Z Tan, H M Tian, Y X Sun, Y Ren, T Chen
{"title":"[X-linked adrenal hypoplasia congenita caused by a novel mutation in NR0B1 (DAX1): a case report].","authors":"J Du, Y Long, X Z Tan, H M Tian, Y X Sun, Y Ren, T Chen","doi":"10.3760/cma.j.cn112138-20240207-00102","DOIUrl":"10.3760/cma.j.cn112138-20240207-00102","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141790158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of the correlation between fatty liver index and myocardial remodeling]. [脂肪肝指数与心肌重塑的相关性分析]。
Pub Date : 2024-07-01 DOI: 10.3760/cma.j.cn112138-20231215-00384
J C Qu, A P Wang, J T Dou, W J Gu, Z H Lyu, Y M Mu

Objective: To analyze the correlation between fatty liver index (FLI) and myocardial remodeling. Methods: For cross-sectional study, cluster sampling was used to conduct a follow-up study of "Risk evaluation of cancers in Chinese diabetic individuals: A longitudinal (REACTION) study" among communities of Gucheng and Pingguoyuan of Beijing from April 2015 to September 2015. According to the inclusion and exclusion criteria, 8 848 participants were selected. Biochemical indicators such as body mass index, waist circumference, triglycerides, and γ-glutamyl transpeptidase were detected to calculate the FLI. The correlation between FLI and myocardial remodeling was analyzed. Interventricular septal thickness (IVS), left atrial diameter (LAD), left ventricular end diastolic diameter (LVEDD), and the presence of diastolic dysfunction were measured by color doppler ultrasound. The participants were divided into Q1 group (FLI<30, 4 529 cases), Q2 group (30≤FLI<60, 2 762 cases), and Q3 group (FLI≥60, 1 557 cases) based on FLI levels. Single factor analysis of variance was used for inter-group comparison, logistic regression analysis was used to analyze the correlation between FLI and myocardial remodeling. Results: A total of 8 848 subjects were selected for the study (3 110 male and 5 738 female, mean age: 59.96 years). The IVS of Q1, Q2, and Q3 groups were (9.35±1.08), (9.73±1.22), and (10.07±1.31) mm, respectively. The LAD were (30.94±3.90), (33.37±4.12), and (34.98±4.47) mm, respectively. The LVEDD were (42.51±5.05), (44.43±5.10), and (46.06±5.52) mm, respectively. All increased with the increase of FLI (all P<0.001). FLI was an independent risk factor for IVS thickening, LAD increase, LVEDD increase, and diastolic function decrease. The respective risks for IVS thickening, LAD increase, LVEDD increase, and diastolic function decrease in a population with intermediate and higher FLI levels was 1.62 times (95%CI 1.39-1.89) and 2.53 times (95%CI 2.13-3.00); 2.71 times (95%CI 2.39-3.06) and 5.00 times (95%CI 4.12-6.08); 2.36 times (95%CI 1.85-3.00) and 4.33 times (95%CI 3.33-5.62); and 1.90 times (95%CI 1.63-2.19) and 1.95 times (95%CI 1.60-2.37) than those with lower FLI levels. Conclusion: There is a certain relevance between FLI and myocardial remodeling.

目的:分析脂肪肝指数(FLI)与心肌重塑之间的相关性:分析脂肪肝指数(FLI)与心肌重塑之间的相关性。方法在横断面研究中,采用聚类抽样法在古城和平谷社区开展 "中国糖尿病患者癌症风险评估纵向研究(REACTION)":纵向研究(REACTION)"的跟踪研究。根据纳入和排除标准,共选取了 8 848 名参与者。通过检测体重指数、腰围、甘油三酯、γ-谷氨酰转肽酶等生化指标来计算FLI。分析了 FLI 与心肌重塑之间的相关性。彩色多普勒超声测量了室间隔厚度(IVS)、左心房直径(LAD)、左心室舒张末期直径(LVEDD)以及是否存在舒张功能障碍。受试者被分为 Q1 组(FLIResults:研究共选取了 8 848 名受试者(男性 3 110 人,女性 5 738 人,平均年龄 59.96 岁)。Q1、Q2 和 Q3 组的 IVS 分别为(9.35±1.08)、(9.73±1.22)和(10.07±1.31)mm。LAD 分别为(30.94±3.90)、(33.37±4.12)和(34.98±4.47)毫米。LVEDD 分别为(42.51±5.05)、(44.43±5.10)和(46.06±5.52)毫米。均随 FLI 的增加而增加(所有 PCI 1.39-1.89)和 2.53 倍(95%CI 2.13-3.00);2.71 倍(95%CI 2.39-3.06)和 5.00 倍(95%CI 4.12-6.08);2.36倍(95%CI为1.85-3.00)和4.33倍(95%CI为3.33-5.62);FLI水平较低者为1.90倍(95%CI为1.63-2.19)和1.95倍(95%CI为1.60-2.37)。结论FLI与心肌重塑之间存在一定的相关性。
{"title":"[Analysis of the correlation between fatty liver index and myocardial remodeling].","authors":"J C Qu, A P Wang, J T Dou, W J Gu, Z H Lyu, Y M Mu","doi":"10.3760/cma.j.cn112138-20231215-00384","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20231215-00384","url":null,"abstract":"<p><p><b>Objective:</b> To analyze the correlation between fatty liver index (FLI) and myocardial remodeling. <b>Methods:</b> For cross-sectional study, cluster sampling was used to conduct a follow-up study of \"Risk evaluation of cancers in Chinese diabetic individuals: A longitudinal (REACTION) study\" among communities of Gucheng and Pingguoyuan of Beijing from April 2015 to September 2015. According to the inclusion and exclusion criteria, 8 848 participants were selected. Biochemical indicators such as body mass index, waist circumference, triglycerides, and γ-glutamyl transpeptidase were detected to calculate the FLI. The correlation between FLI and myocardial remodeling was analyzed. Interventricular septal thickness (IVS), left atrial diameter (LAD), left ventricular end diastolic diameter (LVEDD), and the presence of diastolic dysfunction were measured by color doppler ultrasound. The participants were divided into Q1 group (FLI<30, 4 529 cases), Q2 group (30≤FLI<60, 2 762 cases), and Q3 group (FLI≥60, 1 557 cases) based on FLI levels. Single factor analysis of variance was used for inter-group comparison, logistic regression analysis was used to analyze the correlation between FLI and myocardial remodeling. <b>Results:</b> A total of 8 848 subjects were selected for the study (3 110 male and 5 738 female, mean age: 59.96 years). The IVS of Q1, Q2, and Q3 groups were (9.35±1.08), (9.73±1.22), and (10.07±1.31) mm, respectively. The LAD were (30.94±3.90), (33.37±4.12), and (34.98±4.47) mm, respectively. The LVEDD were (42.51±5.05), (44.43±5.10), and (46.06±5.52) mm, respectively. All increased with the increase of FLI (all <i>P</i><0.001). FLI was an independent risk factor for IVS thickening, LAD increase, LVEDD increase, and diastolic function decrease. The respective risks for IVS thickening, LAD increase, LVEDD increase, and diastolic function decrease in a population with intermediate and higher FLI levels was 1.62 times (95%<i>CI</i> 1.39-1.89) and 2.53 times (95%<i>CI</i> 2.13-3.00); 2.71 times (95%<i>CI</i> 2.39-3.06) and 5.00 times (95%<i>CI</i> 4.12-6.08); 2.36 times (95%<i>CI</i> 1.85-3.00) and 4.33 times (95%<i>CI</i> 3.33-5.62); and 1.90 times (95%<i>CI</i> 1.63-2.19) and 1.95 times (95%<i>CI</i> 1.60-2.37) than those with lower FLI levels. <b>Conclusion:</b> There is a certain relevance between FLI and myocardial remodeling.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141478077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Erdheim-Chester disease manifesting as diabetes insipidus: a case report]. [表现为糖尿病性尿崩症的 Erdheim-Chester 病:病例报告]。
Pub Date : 2024-07-01 DOI: 10.3760/cma.j.cn112138-20231201-00359
J Huang, M Y Guo, H Luo, X X Zuo
{"title":"[Erdheim-Chester disease manifesting as diabetes insipidus: a case report].","authors":"J Huang, M Y Guo, H Luo, X X Zuo","doi":"10.3760/cma.j.cn112138-20231201-00359","DOIUrl":"10.3760/cma.j.cn112138-20231201-00359","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141478079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Progresses and hot spots of percutaneous coronary intervention for coronary artery disease in the past decade]. [近十年经皮冠状动脉介入治疗冠心病的进展与热点]。
Pub Date : 2024-07-01 DOI: 10.3760/cma.j.cn112138-20240113-00034
Q Y Guo, Y J Zhou
{"title":"[Progresses and hot spots of percutaneous coronary intervention for coronary artery disease in the past decade].","authors":"Q Y Guo, Y J Zhou","doi":"10.3760/cma.j.cn112138-20240113-00034","DOIUrl":"10.3760/cma.j.cn112138-20240113-00034","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141478083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华内科杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1